ThirtyFiveBio Ltd
- Biotech or pharma, therapeutic R&D
ThirtyFiveBio is a seed-funded company developing antagonists for GPCR GPR35 for treatment of digestive system diseases with high unmet clinical need
June 16-19, 2025
Boston Convention & Exhibition Center